NEO - ネオス・ファ―マシュ―ティカルズ (NeoGenomics Inc.) ネオス・ファ―マシュ―ティカルズ

 NEOのチャート


 NEOの企業情報

symbol NEO
会社名 Neos Therapeutics Inc (ネオス・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Precision Instruments  
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 事業概要 ネオゲノミクス(NeoGenomics Inc.)はがんに焦点を当てた遺伝子検査ラボのネットワークのオペレーターである。同社は実験室試験事業を運営する。実験室試験事業は病院、病理学者、腫瘍専門医、他の臨床医及び研究者に検査サービスを提供する。同社はフロリダ州マイアーズとタンパ、カリフォルニア州のアリソビエホ、フレズノ、アーバイン、ウエストサクラメント、並びにテキサス州のヒューストンとテネシー州のナッシュビルで実験室を有する。その実験室は細胞遺伝学、蛍光in-situハイブリダイゼーション(FISH)、フローサイトメトリー、免疫組織化学(IHC)、分子検査および病理学相談を含む検査サービスを提供する。製薬サービスと臨床試験グループは、製薬顧客の腫瘍学プログラムを、発見から商品化までサポートするために、テストサービスを提供する。同社は分子スクリーニングのための最適なプラットフォームを推薦し、意味のあるデータを収集するために情報科学を用いてその発見ツールを支援することによって、顧客がバイオマーカー仮説を立てるのに役立つ。   ネオス・ファ―マシュ―ティカルズは米国の医薬品会社。主に薬剤送達技術を利用し、既に商品化されている製薬の改良、開発に従事する。薬剤候補に、注意欠陥多動障害(ADHD)治療薬で、患者の負担が軽い徐放性タイプの経口薬を開発する。また、ADHD治療薬のメチルフェニデ―トとアンフェタミンの両方を取り入れた製薬も開発する。本社はキサス州。   NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad and Fresno California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
本社所在地 2940 N. Hwy. 360 Grand Prairie TX 75050 USA
代表者氏名 Douglas M. VanOort Douglas M. VanOort
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 941-923-1949
設立年月日 34639
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 138人
url www.neostx.com
nasdaq_url https://www.nasdaq.com/symbol/neo
adr_tso
EBITDA EBITDA(百万ドル) 26.99500
終値(lastsale) 14.34
時価総額(marketcap) 1170709082.04
時価総額 時価総額(百万ドル) 1268.162
売上高 売上高(百万ドル) 262.01400
企業価値(EV) 企業価値(EV)(百万ドル) 1397.261
当期純利益 当期純利益(百万ドル) -4.77900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NeoGenomics Inc. revenues increased 10% to $131.2M. Net income applicable to common stockholders totaled $3.7M vs. loss of $5.9M. Revenues reflect Clinical testing segment increase of 7% to $116.5M Pharma Services segment increase of 30% to $14.7M. Net Income reflects Stock-based Compensation in R&D decrease of 18% to $269K (expense).

 NEOのテクニカル分析


 NEOのニュース

   NeoGenomics Exercises Option To Acquire Remaining Stake In Inivata For $390M  2021/05/05 12:38:39 Benzinga
NeoGenomics Inc (NASDAQ: NEO ) has agreed to acquire the remaining stake in Inivata Ltd, a commercial-stage liquid biopsy platform company headquartered in England. The acquisition follows a $25 million minority equity investment by NeoGenomics in Inivata in May last year, at which time NeoGenomics was granted a fixed price option … Full story available on Benzinga.com
   Oppenheimer shares 12 small-company stocks to buy while this unloved part of the market is beaten down and before it makes a comeback  2021/04/20 15:48:05 Business Insider
Summary List Placement Up until this week, it seemed like the stock market would continue enjoying a strong run this year with the S&P 500 having hit all-time highs four times since the beginning of 2021. Most recently, the S&P 500 closed above 4,185 for the first time on April 16. April 1 also marked a closing milestone for the index as it surpassed 4,000 points . The same can't be said of the Russell 2000. Even though small-caps are outperforming their larger counterparts on a year-to-date basis, they've failed to continue generating lofty gains these past couple of months as the Russell 2000's three-month return of 5.2% now lag the S&P 500's performance of nearly 11% . However, the small-cap index still houses some appealing opportunities for investors given that the Russell 2000 is just taking a breather and can resume its powerful run, according to Ari Wald, the head of technical analysis at Oppenheimer & Co. That's because technical analysis shows small caps failed to reach fresh highs in April as a result of a bull-market rotation rather than money becoming less concentrated at a major peak.
   If You Invested $1,000 In Neo Crypto On Jan. 1, Here's How Much You Would Have Now  2021/04/19 05:36:25 Benzinga
Neo (NEO) emerged as China’s first public blockchain … Full story available on Benzinga.com
   BTC, ETH, XRP, TRX, IOTA, NEO, ATOM: Technical Analysis March 23  2021/03/23 10:49:00 BeInCrypto
XRP (XRP) is following a descending resistance line. It is expected to break out. TRON (TRX) has fallen below the $0.061 support level, but is expected to reclaim it. Iota (IOTA) has broken out from a descending resistance line. Neo (NEO) and Cosmos (ATOM) are trading inside parallel ascending channels. They have failed to break … Continued The post BTC, ETH, XRP, TRX, IOTA, NEO, ATOM: Technical Analysis March 23 appeared first on BeInCrypto .
   Khởi động cuộc thi Hoa khôi Hòa bình Việt Nam 2021 tại Đà Nẵng  2021/03/20 11:06:36 VietnamPlus
Tại buổi họp báo công bố thông tin chính thức về Cuộc thi Hoa khôi Hòa bình Việt Nam 2021, tổ chức tại Đà Nẵng, bà Nguyễn Thị Thanh Thủy, Giám đốc Công ty trách nhiệm hữu hạn Thương mại và Dịch vụ Minh Khang Việt Nam, đơn vị tổ chức cuộc thi, cho biết cuộc thi chính thức được khởi động từ ngày 20/3. Cuộc thi sẽ tiếp nối, duy trì truyền thống các cuộc thi sắc đẹp Việt Nam nhằm tôn vinh quảng bá vẻ đẹp tâm hồn, nhân cách lối sống, rèn luyện thể chất, trí tuệ, tài năng và bản lĩnh của thiếu nữ Việt Nam. Cuộc thi còn là hoạt động văn hóa nhằm định hướng giáo dục thẩm mỹ cho tuổi trẻ Việt Nam, qua đó tuyển chọn những nữ công dân có đạo đức tốt, có trình độ văn hóa, vẻ đẹp tiêu biểu của phụ nữ Việt Nam để trao danh hiệu Hoa khôi Hòa bình. Cuộc thi cũng góp phần lựa chọn đại diện cho phái đẹp Việt Nam tham dự các cuộc thi nhan sắc quốc tế. Phó Giám đốc Sở Văn hóa và Thể thao Đà Nẵng, Nguyễn Thị Hội An cho biết với mục tiêu xây dựng Đà Nẵng trở thành thành phố của sự kiện và du lịch, trong những năm qua, chính quyền thành phố luôn tạo mọi điều kiện thuận lợi để các sự kiện được diễn ra trên địa bàn thành phố.
   NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition  2021/02/02 13:00:00 PR Newswire
/PRNewswire/ -- The Access to Comprehensive Genomic Profiling Coalition (ACGP) announced today the addition of NeoGenomics, Inc. (NASDAQ: NEO) and Tempus to…
   Bitcoin Holds Steady Above USD 30K, Ethereum and Altcoins Gain Traction  2021/01/28 13:21:04 cryptonews.com
Bitcoin price is stable above USD 30,500 and USD 31,000. BTC is currently (13:00 UTC) attempting an upside break above USD 31,800 and USD 32,000. A close above USD 32,000 could open the doors for a larger increase in the coming sessions. Besides, most major altcoins are showing signs of a fresh increase, including ethereum, EOS, XRP, XLM, LINK, BNB, OMG, NEO, TRX, bitcoin cash, DOT, litecoin, and
   The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement  2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
   Routemaster Capital Graduates Public Listing to NEO Exchange  2021/01/21 15:27:00 Business Wire
TORONTO--(BUSINESS WIRE)-- #listing--Routemaster Capital Inc. (NEO:DEFI), a Canadian decentralized finance company, is now trading no NEO.
   A History of Price Movements for NEO - BeInCrypto  2021/01/19 15:26:05 BeInCrypto
While the NEO price has increased considerably since its March 2020 low, it's not even close to reaching its all-time high. NEO is unlike…
   China Stance on Crypto Remains The Same; Blockchain, Not Bitcoin  2020/12/04 19:39:08 BitcoinExchangeGuide
In a recent report by Chinese state media Xinhuanet, the Chinese government wants its citizens to stop paying attention to cryptocurrency but concentrate more on blockchain technology, the technology behind the cryptocurrencies. China is emphasizing that the current rise of almost all crypto coins could seem very attractive to investors, which may not be permanent. According to the media report, the warning is to protect the Chinese citizens and residents from making life-damaging investment decisions. However, it encourages citizens to invest more time and resources in Blockchain technology since it can be applied in various industries. The past few weeks had seen the upsurge of Bitcoin price, as it moved above its previous all-time high achieved in 2017 when it reached $20,000 per Bitcoin. The same story goes for other cryptocurrencies. Some even tripled in price, representing massive investment profits for the crypto holder. Bitcoin’s direction is uncertain Various market analysts have predicted on the recent Bull Run and where the market is headed next.
   Moonstake Collaboration Webinar: "The future of blockchain: the case of Neo3" - Stocks News Feed  2020/12/03 04:56:06 Stocks News Feed
SINGAPORE, Dec 3, 2020 – (ACN Newswire) – Moonstake will hold a joint webinar with NEO, “The future of blockchain: the case of NEO3” on 3rd of Dec, 2020. It will be held from 3PM Singapore/Beijing time. NEO, also known as Ethereum in China, launched the mainnet three years ago and has been in stable… Read More »Moonstake Collaboration Webinar: “The future of blockchain: the case of Neo3”
   Neo führt Kinder in die Digitalwelt  2020/12/02 15:25:35 W&V
Mit der Smartwatch von Disney und Vodafone kann der Nachwuchs Fotografieren, Bewegungen tracken - und natürlich mit den Eltern in Verbindung bleiben. Die behalten über eine App die volle Kontrolle.
   $NEO $NEOUSD #NEO - Daily  2020/12/02 14:47:38 CentralCharts
The bullish trend is currently very strong on NEO - NEO/USD. As long as the price remains above the support at 16.47 USD, you could try to benefit from the boom. The first bullish objective is located at 18.70 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 20.48 USD as an objective. Crossing it would then enable buyers to target 25.16 USD. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
   The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback  2020/11/25 12:35:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) AbbVie Inc (NYSE: ABBV ) Affimed NV (NASDAQ: AFMD ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cellectis SA (NASDAQ: CLLS ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Generation Bio Co (NASDAQ: GBIO ) Inspire Medical Systems Inc (NYSE: INSP ) Kronos Bio Inc (NASDAQ: KRON ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) NeoGenomics, Inc. (NASDAQ: NEO ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pulmonx Corp (NASDAQ: LUNG ) Relay Therapeutics Inc (NASDAQ: RLAY ) Sotera Health Co (NASDAQ: SHC ) (began trading on Nasdaq Friday following its IPO) Trinity Biotech plc (NASDAQ: TRIB ) Veracyte Inc (NASDAQ: VCYT ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 24) Advaxis, Inc. (NASDAQ: ADXS ) ( announced a public offering of common stock and warrants) Immunome Inc (NASDAQ: IMNM ) InMed Pharmaceuticals Inc (NASDAQ: INM ) Kiromic Biopharma Inc (NASDAQ: KRBP ) Maravai Lifesciences Holdings Inc (NASDAQ: MRVI ) debuted on Wall Street Friday) Qualigen …

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 ネオス・ファ―マシュ―ティカルズ NEO NeoGenomics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)